Being Precise About Precision Medicine: What Should Value Frameworks Incorporate to Address Precision Medicine? A Report of the Personalized Precision Medicine Special Interest Group

Eric Faulkner*, Anke Peggy Holtorf, Surrey Walton, Christine Y. Liu, Hwee Lin, Eman Biltaj, Diana Brixner, Charles Barr, Jennifer Oberg, Gurmit Shandhu, Uwe Siebert, Susan R. Snyder, Simran Tiwana, John Watkins, Maarten J. IJzerman, Katherine Payne

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

66 Citations (Scopus)
253 Downloads (Pure)

Abstract

Precision medicine is a dynamic area embracing a diverse and increasing type of approaches that allow the targeting of new medicines, screening programs or preventive healthcare strategies, which include the use of biologic markers or complex tests driven by algorithms also potentially taking account of patient preferences. The International Society for Pharmacoeconomics and Outcome Research expanded its current work around precision medicine to (1) describe the evolving paradigm of precision medicine with examples of current and evolving applications, (2) describe key stakeholders perspectives on the value of precision medicine in their respective domains, and (3) define the core factors that should be considered in a value assessment framework for precision medicine. With the ultimate goal of improving health of well-defined patient groups, precision medicine will affect all stakeholders in the healthcare system at multiple levels spanning the individual perspective to the societal perspective. For an efficient, timely and practical precision medicine value assessment framework, it will be important to address these multiple perspectives through building consensus among the stakeholders for robust procedures and measures of value aspects, including performance of precision mechanism; aligned reimbursement processes of precision mechanism and subsequent treatment; transparent expectations for evidence requirements and study designs adequately matched to the intended use of the precision mechanism and to the smaller target patient populations; recognizing the potential range of value-generation such as ruling-in and ruling-out decisions.

Original languageEnglish
Pages (from-to)529-539
Number of pages11
JournalValue in Health
Volume23
Issue number5
DOIs
Publication statusPublished - 1 May 2020

Bibliographical note

Funding Information:
We extend special thanks to Theresa Tesoro and Clarissa Cooblall at ISPOR, the professional society for health economics and outcomes research. We especially thank the individuals who submitted written comments on drafts of our manuscript; Gouri Shankar Bhattacharyya, Cornelis Boersma, Benjamin Craig, Godofreda Dalmacion, Beth Devine, Tatiana Dilla, Clare Foy, Lou Garrison, M. Ragan Hart, John Hornberger, Reuben Howden, J Ross Maclean, Ethna McFerran, Kathryn Phillips, Molly Purser, Brock Schroeder, Scott Spencer, Vincenzo Straccia, Renske ten Ham, Kevin Wilson, and Lin Zhang. All authors volunteered their time for discussion, research, and writing of this report. This research was supported in part by ISPOR, which contributed two staff liaisons for this project.

Publisher Copyright:
© 2020 ISPOR–The Professional Society for Health Economics and Outcomes Research

Fingerprint

Dive into the research topics of 'Being Precise About Precision Medicine: What Should Value Frameworks Incorporate to Address Precision Medicine? A Report of the Personalized Precision Medicine Special Interest Group'. Together they form a unique fingerprint.

Cite this